Exelixis Inc (NASDAQ:EXEL) - Overview

Stock Report

Exelixis Inc EXEL

Last Price
$17.37

Day Change
0.85|5.15%

As of 02/12/2016
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close16.52
Day Range16.42 - 17.74
Mkt Cap5.11Bil
52-Wk Range3.55 - 17.74
Yield %-
ISINUS30161Q1040
Volume6,884,261
P/E-26.32
P/S33.02
P/CF46.92

Share Price

Financials
201320142015
More ...
Income Statement
Revenue31.3425.1137.17
Operating Income-200.73-224.46-121.42
Net Income-244.76-268.54-169.74
Basic EPS-1.33-1.38-0.81
Avg. Diluted Shares Outstanding184194209
Balance Sheet
Current Assets266.61167.24178.67
Non Current Assets236.68160.72153.68
Total Assets503.29327.96332.34
Current Liabilities87.85171.8652.25
Total Liabilities437.05442.79436.65
Total Equity66.24-114.83-104.30
Cash Flow
Operating Cash Flow-198.77-235.41-141.59
Capital Expenditure-2.17-0.47-0.45
Free Cash Flow-200.94-235.88-142.03

In millions, except "Basic EPS". Currency is USD.

Company Profile

Exelixis Inc is a biotechnology company that develops small molecule therapies for the treatment of cancer.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Mid-Blend

Fiscal Year Ends

December

Employees

115
Key Stats
More ...
Price/Earning TTM-25.03
Price/Book147.76
Price/Sales TTM52.15
Rev Growth (3 year avg)-7.82
EPS Growth (3 year avg)-
Operating Margin % TTM-326.65
Net Margin % TTM-456.63
ROE TTM-
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.